According to Fox News AI on Twitter, the U.S. Food and Drug Administration launched an AI-powered pharmacovigilance system to track drug and vaccine side effects nationwide, aiming to improve signal detection speed and accuracy (as reported by Fox News). According to Fox News, the system will analyze large-scale real‑world data such as adverse event reports and health records to identify safety signals earlier, which could shorten investigation timelines and enhance post‑market monitoring. As reported by Fox News, the move positions the FDA to scale automated triage and prioritization of safety cases, potentially reducing manual review burdens for manufacturers and payers while improving patient safety oversight.